Biography
Dr. Juan Wisnivesky is Professor of Medicine and Chief of the Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai. He is a health services investigator with a research interest in chronic pulmonary disease self-management, lung cancer outcomes, disparities in care, and Covid-19.
Dr. Wisnivesky has received multiple grants from the National Institutes of Health to support his research and he directs a federally funded Cancer Prevention and Control Training Program focused on underserved priority populations. He has published several manuscripts addressing issues related to lung cancer epidemiology, asthma, chronic obstructive pulmonary disease and more recently regarding the post-acute complications of COVID-19 infection. His research has unveiled the rates and underlying reasons for disparities in lung cancer care and has shown that lung cancer has a more benign progression in women, suggesting biological differences in behavior. He has used novel statistical tools to answer key questions about lung cancer treatment in older adults, which were incorporated into clinical guidelines.
He has mentored and trained dozens of medical students, residents, fellows, and junior faculty, many of whom have moved to independent research careers and academic leadership roles. Dr. Wisnivesky is an active faculty in the American Thoracic Society’s MECOR Program and was appointed to the Coordinating Committee for the National Heart, Lung, and Blood Institute National Asthma Education and Prevention Program. He is also Chair of the Health Equality Committee of the American Thoracic Society and a member of the American Society for Clinical Investigation.
Dr. Juan Wisnivesky is Professor of Medicine and Chief of the Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai. He is a health services investigator with a research interest in chronic pulmonary disease self-management, lung cancer outcomes, disparities in care, and Covid-19.
Dr. Wisnivesky has received multiple grants from the National Institutes of Health to support his research and he directs a federally funded Cancer Prevention and Control Training Program focused on underserved priority populations. He has published several manuscripts addressing issues related to lung cancer epidemiology, asthma, chronic obstructive pulmonary disease and more recently regarding the post-acute complications of COVID-19 infection. His research has unveiled the rates and underlying reasons for disparities in lung cancer care and has shown that lung cancer has a more benign progression in women, suggesting biological differences in behavior. He has used novel statistical tools to answer key questions about lung cancer treatment in older adults, which were incorporated into clinical guidelines.
He has mentored and trained dozens of medical students, residents, fellows, and junior faculty, many of whom have moved to independent research careers and academic leadership roles. Dr. Wisnivesky is an active faculty in the American Thoracic Society’s MECOR Program and was appointed to the Coordinating Committee for the National Heart, Lung, and Blood Institute National Asthma Education and Prevention Program. He is also Chair of the Health Equality Committee of the American Thoracic Society and a member of the American Society for Clinical Investigation.
